A population of 741 million people makes Europe a huge market for drugmakers, yet most investors avoid European healthcare stocks in their portfolios. Is that a mistake? It could be, especially when it comes to Sanofi SA (NYSE: SNY), a French biopharma giant that's trading at a reasonable valuation and offers a market-trouncing dividend yield.
Don’t Ignore European Healthcare Stocks
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться